Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis (Q42248672)

19 October 2017

Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis (English)

1 reference

19 October 2017

Sonya Marshall-Gradisnik

9

object named as

Sonya M Marshall-Gradisnik

1 reference

19 October 2017

Sharni Lee Hardcastle

3

object named as

Sharni L Hardcastle

1 reference

19 October 2017

Ekua Weba Brenu

1

1 reference

19 October 2017

Teilah K Huth

2

1 reference

19 October 2017

Kirsty Fuller

4

1 reference

19 October 2017

Manprit Kaur

5

1 reference

19 October 2017

Samantha Johnston

6

1 reference

19 October 2017

Sandra B Ramos

7

1 reference

19 October 2017

Don R Staines

8

1 reference

19 October 2017

16 December 2013

1 reference

19 October 2017

International Immunology

1 reference

19 October 2017

26

1 reference

19 October 2017

4

1 reference

19 October 2017

233-242

1 reference

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

19 October 2017

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Cognitive behavior therapy in patients with chronic fatigue syndrome: the role of illness acceptance and neuroticism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Treatment outcome in adults with chronic fatigue syndrome: a prospective study in England based on the CFS/ME National Outcomes Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Mania and recovery from chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Immune and hemorheological changes in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

How do regulatory T cells work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFN-beta and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

The pathogenic role of tissue-resident immune cells in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Gammadelta T cells: functional plasticity and heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Gammadelta T cells - innate immune lymphocytes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

T-cell receptor-gamma/delta bearing lymphocytes in normal and inflammatory human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Emerging role of gammadelta T-cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Roles of γδ T cells in the pathogenesis of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Phenotypic characterization of gammadelta T cells mobilized in response to acute psychological stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Relationship between CD107a expression and cytotoxic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

CD107a as a functional marker for the identification of natural killer cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

VPAC and PAC receptors: From ligands to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Human neutrophil alloantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Neutrophil CD177 (NB1 gp, HNA-2a) expression is increased in severe bacterial infections and polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Granulocyte gene polymorphisms and mutations: effects on immune response and neutrophil proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

CD177: A member of the Ly-6 gene superfamily involved with neutrophil proliferation and polycythemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Neutrophil-specific antigen HNA-2a (NB1, CD177): serology, biochemistry, and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

21 January 2018

Neutrophil alloantigens

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Neutrophil transmigration mediated by the neutrophil-specific antigen CD177 is influenced by the endothelial S536N dimorphism of platelet endothelial cell adhesion molecule-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Cytotoxic activity of the lymphocyte toxin granzyme B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Mechanisms and implications of age-associated impaired innate interferon secretion by dendritic cells: a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Type I interferon (IFN-alpha/beta) rescues B-lymphocytes from apoptosis via PI3Kdelta/Akt, Rho-A, NFkappaB and Bcl-2/Bcl(XL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Interferon production in postviral fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Peripheral B cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: decreased memory B cells and membrane CD19 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Atacicept: targeting B cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Heterogeneity in the differentiation and function of memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Phenotypic and functional heterogeneity of human memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Adenosine and IFN-{alpha} synergistically increase IFN-gamma production of human NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Adenosine suppresses alpha(4)beta(7) integrin-mediated adhesion of T lymphocytes to colon adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Adenosine: an endogenous regulator of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXT068

21 January 2018

Identifiers

DOI

10.1093/INTIMM/DXT068

1 reference

19 October 2017

1 reference